Published

Motives for Classical and Novel Psychoactive Substances Use in Psychedelic Polydrug Users

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Contemporary Drug Problems
Date: 2019-09-01
Source: OpenAlex
DOI: 10.1177/0091450919863899
PubMed: Unavailable

Authors

Hannes Kettner Natasha L. Mason Kim P. C. Kuypers

Watch author

Derived topics and classifications

psilocybin Addiction Receptor Pharmacology Consciousness Observational Study Toxicity Observational Study

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Motives for Classical and Novel Psychoactive Substances Use in Psychedelic Polydrug Users2019-09-01

Related papers

Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapyJournal of Psychedelic Studies · 2026-08-13 Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin ServicesJAMA Network Open · 2026-08-19 An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10 Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. AdultsAmerican Journal of Preventive Medicine · 2026-10-01 Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal StudiesVCU Scholars Compass (Virginia Commonwealth University) · 2026-08-21 Defining 'psychedelic'.Journal of psychopharmacology (Oxford, England) · 2026-08-17 The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14 Psychedelics align brain activity with context.Nature · 2026-08-19